Showing results (31-40 of 116) with videos related to
Sort By:
Pageof 12
Presse Medicale (Paris, France : 1983)|December 3, 1994
[Macrolides. New therapeutic prospects]A Bryskier, M T LabroThe Journal of Antimicrobial Chemotherapy|July 1, 1997
Ketolides lack inducibility properties of MLS(B) resistance phenotypeA Bonnefoy, A M Girard, C Agouridas, et al.Antimicrobial Agents and Chemotherapy|August 17, 2002
Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebaeM Maurin, A Bryskier, D RaoultAntimicrobial Agents and Chemotherapy|April 1, 1995
Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophagesN Rastogi, V Labrousse, A BryskierAntimicrobial Agents and Chemotherapy|June 13, 1998
A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycinA Rosato, H Vicarini, A Bonnefoy, et al.The Journal of Antibiotics|March 1, 1991
New ether oxime derivatives of erythromycin A. A structure-activity relationship studyJ C Gasc, S G d'Ambrieres, A Lutz, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|November 18, 1980
[Septicemia due to polyresistant Staphylococcus aureus (author's transl)]J P Bonnardot, R Bonvoisin, A BryskierJournal of Chemotherapy (Florence, Italy)|April 15, 2005
In vitro evaluation of faropenem activity against anaerobic bacteriaJ Behra-Miellet, L Dubreuil, A BryskierAntimicrobial Agents and Chemotherapy|July 1, 1993
In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICsN Rastogi, K S Goh, A BryskierAntimicrobial Agents and Chemotherapy|February 19, 2000
Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophilsD Vazifeh, A Bryskier, M T LabroPageof 12